# A Study of Residual Curarization Incidence in China

> **NCT01690338** · PHASE4 · UNKNOWN · sponsor: **Peking University First Hospital** · enrollment: 6090 (estimated)

## Conditions studied

- Perioperative/Postoperative Complications
- PORC (Postoperative Residual Curarization)

## Interventions

- **DRUG:** Vecuronium Bromide
- **DRUG:** Rocuronium
- **DRUG:** Cisatracurium

## Key facts

- **NCT ID:** NCT01690338
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-10
- **Primary completion:** 2014-10
- **Final completion:** 2014-12
- **Target enrollment:** 6090 (ESTIMATED)
- **Last updated:** 2013-05-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01690338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01690338, "A Study of Residual Curarization Incidence in China". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01690338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*